Quantcast

Latest autoimmune diseases Stories

2014-11-17 08:32:05

Same eczema-soothing power, with a new look FORT WORTH, Texas, Nov.

2014-11-16 16:21:13

- Secukinumab met primary endpoints demonstrating statistically significant improvements versus placebo in signs and symptoms of active psoriatic arthritis (PsA) in two pivotal Phase III studies

2014-11-15 16:21:18

- Secukinumab is the first selective IL-17A inhibitor to significantly improve signs and symptoms of ankylosing spondylitis (AS) versus placebo in Phase III studies EAST HANOVER, N.J., Nov.

2014-11-14 16:24:37

November 14 is World Diabetes Day CHICAGO, Nov.

2014-11-12 04:23:22

PARIS, November 12, 2014 /PRNewswire/ -- Collaboration to generate novel diagnostic products to support personalized therapies for

2014-11-10 08:33:47

Be Joint Smart to educate roughly 48,000 local residents with PsA about their disease PORTLAND, Ore., Nov.

2014-11-10 08:32:16

- Four pivotal Phase III studies of secukinumab in psoriatic arthritis (PsA) and ankylosing spondylitis (AS) to be presented for the first time at ACR 2014 EAST HANOVER, N.J., Nov.

2014-11-08 23:01:42

ReportsnReports.com adds “Bullous Pemphigoid Global Clinical Trials Review, H2, 2014” to its store.

2014-11-07 16:24:10

Expert from the University of California San Francisco, regarded as one the world's leading academic centers in health sciences, will lead a discussion on pulmonary fibrosis in scleroderma.


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.